Onapgo

Active Ingredient(s): Apomorphine Hydrochloride
FDA Approved: * February 3, 2025
Pharm Company: * MDD US OPS LLC A SUB OF SUPERNUS PHARMA INC
Category: Parkinsons

Apomorphine, sold under the brand name Apokyn among others, is a type of aporphine having activity as a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors.[1] It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Contrary to its name, apomorphine d... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Onapgo 4.9 mg/ml Subcutaneous Injection, Solution
NDC: 27505-006
Labeler:
Mdd Us Operations, LLC, a Subsidiary of Supernus Pharmaceuticals, Inc

Related Brands

Drugs with the same active ingredients